Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32


The potential HLA Class I-restricted epitopes derived from LeIF and TSA of Leishmania donovani evoke anti-leishmania CD8+ T lymphocyte response.

Dikhit MR, Das S, Mahantesh V, Kumar A, Singh AK, Dehury B, Rout AK, Ali V, Sahoo GC, Topno RK, Pandey K, Das VNR, Bimal S, Das P.

Sci Rep. 2018 Sep 21;8(1):14175. doi: 10.1038/s41598-018-32040-x.


Noninvasive Sweat-Based Diagnosis of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis.

Topno RK, Shankar V, Dikhit MR, Madhukar, Pandey K, Das VNR, Kumar M, Kumar B, Agrawal K, Siddiqui NA, Sahoo GC, Kumar R, Singh AK, Kumar R, Das P.

Am J Trop Med Hyg. 2018 Sep 10. doi: 10.4269/ajtmh.17-0749. [Epub ahead of print]


Acid-Sensing Ion Channels structural aspects, pathophysiological importance and experimental mutational data available across various species to target human ASIC1.

Chauhan AS, Sahoo GC, Dikhit MR, Das P.

Curr Drug Targets. 2018 Aug 19. doi: 10.2174/1389450119666180820103316. [Epub ahead of print]


In-silico screening and validation of high-affinity tetra-peptide inhibitor of Leishmania donovani O-acetyl serine sulfhydrylase (OASS).

Kant V, Vijayakumar S, Sahoo GC, Chaudhery SS, Das P.

J Biomol Struct Dyn. 2018 Feb 7:1-14. doi: 10.1080/07391102.2018.1429315. [Epub ahead of print]


Identification of Potential MHC Class-II-Restricted Epitopes Derived from Leishmania donovani Antigens by Reverse Vaccinology and Evaluation of Their CD4+ T-Cell Responsiveness against Visceral Leishmaniasis.

Dikhit MR, Kumar A, Das S, Dehury B, Rout AK, Jamal F, Sahoo GC, Topno RK, Pandey K, Das VNR, Bimal S, Das P.

Front Immunol. 2017 Dec 14;8:1763. doi: 10.3389/fimmu.2017.01763. eCollection 2017.


Computational elucidation, mutational and hot spot-based designing of potential inhibitors against human acid-sensing ion channels (hASIC-1a) to treat various physiological conditions.

Chauhan AS, Ansari MY, Mansuri R, Dikhit MR, Ali V, Sahoo GC, Das P.

J Biomol Struct Dyn. 2017 Nov 20:1-18. doi: 10.1080/07391102.2017.1392364. [Epub ahead of print]


Role of inhibitors of serine peptidases in protecting Leishmania donovani against the hydrolytic peptidases of sand fly midgut.

Verma S, Das S, Mandal A, Ansari MY, Kumari S, Mansuri R, Kumar A, Singh R, Saini S, Abhishek K, Kumar V, Sahoo GC, Das P.

Parasit Vectors. 2017 Jun 23;10(1):303. doi: 10.1186/s13071-017-2239-9.


Mining the Proteome of Leishmania donovani for the Development of Novel MHC Class I Restricted Epitope for the Control of Visceral Leishmaniasis.

Dikhit MR; Vijayamahantesh, Kumar A, Amit A, Dehury B, Nathsharma YP, Ansari MY, Ali V, Topno RK, Das V, Pandey K, Sahoo GC, Bimal S, Das P.

J Cell Biochem. 2018 Jan;119(1):378-391. doi: 10.1002/jcb.26190. Epub 2017 Jun 30.


In Vitro Evaluation of Antileishmanial Activity of Computationally Screened Compounds against Ascorbate Peroxidase To Combat Amphotericin B Drug Resistance.

Mansuri R, Kumar A, Rana S, Panthi B, Ansari MY, Das S, Dikhit MR, Sahoo GC, Das P.

Antimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e02429-16. doi: 10.1128/AAC.02429-16. Print 2017 Jul.


Inhibitor designing, virtual screening, and docking studies for methyltransferase: A potential target against dengue virus.

Singh J, Kumar M, Mansuri R, Sahoo GC, Deep A.

J Pharm Bioallied Sci. 2016 Jul-Sep;8(3):188-94. doi: 10.4103/0975-7406.171682.


Evaluating the Impact of Breastfeeding on Rotavirus Antigenemia and Disease Severity in Indian Children.

Das S, Sahoo GC, Das P, Singh UK, Jaiswal AK, Singh P, Kumar R, Kumar R.

PLoS One. 2016 Feb 1;11(2):e0146243. doi: 10.1371/journal.pone.0146243. eCollection 2016.


Up-regulation of cytosolic tryparedoxin in Amp B resistant isolates of Leishmania donovani and its interaction with cytosolic tryparedoxin peroxidase.

Suman SS, Equbal A, Zaidi A, Ansari MY, Singh KP, Singh K, Purkait B, Sahoo GC, Bimal S, Das P, Ali V.

Biochimie. 2016 Feb;121:312-25. doi: 10.1016/j.biochi.2015.12.017. Epub 2015 Dec 30.


Development of PLGA-PEG encapsulated miltefosine based drug delivery system against visceral leishmaniasis.

Kumar R, Sahoo GC, Pandey K, Das VNR, Topno RK, Ansari MY, Rana S, Das P.

Mater Sci Eng C Mater Biol Appl. 2016 Feb;59:748-753. doi: 10.1016/j.msec.2015.10.083. Epub 2015 Oct 29.


Establishment of correlation between in-silico and in-vitro test analysis against Leishmania HGPRT to inhibitors.

Ansari MY, Equbal A, Dikhit MR, Mansuri R, Rana S, Ali V, Sahoo GC, Das P.

Int J Biol Macromol. 2016 Feb;83:78-96. doi: 10.1016/j.ijbiomac.2015.11.051. Epub 2015 Nov 23.


Binding Pattern Elucidation of NNK and NNAL Cigarette Smoke Carcinogens with NER Pathway Enzymes: an Onco- Informatics Study.

Jamal QM, Dhasmana A, Lohani M, Firdaus S, Ansari MY, Sahoo GC, Haque S.

Asian Pac J Cancer Prev. 2015;16(13):5311-7.


Interaction between Nbp35 and Cfd1 proteins of cytosolic Fe-S cluster assembly reveals a stable complex formation in Entamoeba histolytica.

Anwar S, Dikhit MR, Singh KP, Kar RK, Zaidi A, Sahoo GC, Roy AK, Nozaki T, Das P, Ali V.

PLoS One. 2014 Oct 1;9(10):e108971. doi: 10.1371/journal.pone.0108971. eCollection 2014.


Computational Identification of microRNA-like Elements in Leishmania major.

Sahoo GC, Ansari MY, Dikhit MR, Gupta N, Rana S, Das P.

Microrna. 2014;2(3):225-30.


Structure, evolution and virtual screening of NDM-1 strain from Kolkata.

Sahoo GC, Rani M, Ansari Y, Jha C, Rana S, Dikhit MR, Moharana KC, Kumar R, Das P.

Int J Bioinform Res Appl. 2014;10(3):235-63. doi: 10.1504/IJBRA.2014.060761.


TLR9 and MyD88 are crucial for the maturation and activation of dendritic cells by paromomycin-miltefosine combination therapy in visceral leishmaniasis.

Das S, Rani M, Rabidas V, Pandey K, Sahoo GC, Das P.

Br J Pharmacol. 2014 Mar;171(5):1260-74. doi: 10.1111/bph.12530.


Study the effects of PLGA-PEG encapsulated amphotericin B nanoparticle drug delivery system against Leishmania donovani.

Kumar R, Sahoo GC, Pandey K, Das V, Das P.

Drug Deliv. 2015 May;22(3):383-8. doi: 10.3109/10717544.2014.891271. Epub 2014 Mar 6.


Supplemental Content

Loading ...
Support Center